Jore, Baby Boy .
HRN: 22-41-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/08/2023
01/14/2023
IVT
42 Mg
Od
Psnb
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes